Alterations in Nasal Function Following Total Laryngectomy and Their Clinical Correlates Authors: Kajornpan Sermwittayawong, Paraya Assanasen, Phawin Keskool, Dichapong Kanjanawasee Published: 2026 ABSTRACT ABSTRACTIntroductionAlthough nasal structural and functional changes after total laryngectomy (TL) have been documented, the influence of clinical variables and symptoms remains underexplored. This study compared nasal structure and function between TL patients and healthy controls and identified clinical factors associated with these changes.MethodsA cross‐sectional study was conducted on male patients with laryngeal cancer post‐TL and healthy male volunteers. Objective nasal assessments included the saccharin test for mucociliary clearance time (MCT), acoustic rhinometry for nasal volume and minimal cross‐sectional area (MCA), and contractility index calculated from changes pre‐ and post‐decongestant. Nasal symptom scores were also collected.ResultsForty participants were enrolled (20 per group). Mean MCT was significantly longer in the TL group (10.99 ± 8.41 min) than in controls (6.69 ± 3.72 min; p = 0.047). Mean nasal volume and MCA were comparable between groups (p = 0.77 and 0.31, respectively), as were contractility indices (p = 0.13 and 0.64). Multiple linear regression revealed postoperative duration and smoking amount as significant predictors of increased MCA. Nasal symptoms were reported by 70% of TL patients. Dry nose was negatively correlated with changes in nasal volume and contractility index (r = –0.44 and –0.46, respectively).ConclusionTL patients exhibited prolonged MCT despite no significant morphometric differences. Postoperative duration and smoking exposure were associated with increased MCA, suggesting potential confounding. Reduced nasal contractility was associated with dry nose symptoms. Overall, these findings suggest an effect of nasal airflow deprivation on nasal physiology and may inform future targeted interventions. Introduction Total laryngectomy (TL) is the mainstay treatment for patients with advanced‐stage laryngeal carcinoma, including T4 disease, selected T3 cases, and as a salvage surgery option [1]. This procedure permanently bypasses the upper airway, interrupting airflow through the nose and paranasal sinuses. As a result, both physical and physiological changes occur in the upper airway [2]. The loss of nasal airflow eliminates the natural process of warming, humidifying, and filtering inspired air, allowing unfiltered and unconditioned air to directly enter the trachea. This alteration has been associated with diminished smell and taste perception [3]. Following laryngectomy, several nasal changes begin to develop. A reduction in nasal blood flow has been observed, which may help explain the functional and structural alterations of the nasal mucosa after surgery [4]. While some mechanisms are centrally mediated, the nasal cycle is thought to be preserved, even in the absence of nasal airflow [5]. Over time, these changes can lead to long‐term mucosal atrophy and chronic bacterial colonization, ultimately impairing mucociliary clearance and nasal function [6, 7]. Atrophic mucosa is characterized by a loss of goblet cells, cilia, and submucosal glands, along with stromal fibrosis and lamina propria edema [7, 8]. These degenerative changes are believed to progress over a 2‐year postoperative period [9]. Additionally, increased basal cell hyperplasia in the nasal epithelium has been demonstrated in laryngectomized patients compared to healthy controls [8]. Several studies have also reported elevated bacterial colonization in the nasal cavity without accompanying inflammatory infiltration [7, 8, 10]. These effects may contribute to a higher burden of both subjective and objective nasal dysfunction in laryngectomized patients compared to non‐laryngectomized individuals [11]. Although nasal structural and functional changes after laryngectomy have been documented, the role of contributing clinical variables and symptoms remains insufficiently explored. Moreover, since air conditioning is influenced by geographic and environmental conditions, regional and racial factors may also affect nasal responses post‐laryngectomy. Studies focusing on Asian populations remain limited and underreported [12, 13]. This study aimed to compare nasal structure and function between patients who underwent TL and healthy controls, and to identify clinical factors associated with the observed changes. Material and Methods Study Design A cross‐sectional study of male patients with laryngeal cancer who had undergone TL (TL group) was compared with healthy volunteers. (control group) The study was approved by Siriraj Institutional Review board (SIRB), Faculty of Medicine Siriraj Hospital, Mahidol University (SIRB Protocol No. 383/2562). Subjects This study was conducted at outpatient unit of the Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University between October 2019 and December 2020. The inclusion criteria for TL group were 40‐ to 80‐year‐old male patients with laryngeal cancer who had undergone TL and had been followed up for at least 6 months at the time of recruitment. All eligible patients were consecutively recruited during the study period. Male patients were selected due to their higher prevalence both at our center and globally (80%–90% predominance) [14, 15, 16, 17, 18], to standardize baseline characteristics. The control group consisted of healthy male volunteers recruited through poster announcements and randomly selected from otorhinolaryngology clinic attendees who met the recruitment criteria. The number of controls was matched to the number of TL cases to ensure comparability between the groups. The exclusion criteria were: (1) other head and neck cancers or other mucociliary disorders, (2) history of abnormal nasal structures or documentation of abnormal nasal telescopy, (3) history of nasal or sinus surgery, (4) ongoing respiratory infection, (5) taking decongestant, antihistamine, anti‐leukotrienes, or steroids within 1 week before the study, (6) history of saccharin allergy, (7) could not be performed the saccharin test or acoustic rhinometry. Outcome Measurement After informed consent was obtained, subjects in both groups were asked to complete the case record form. An ENT examination and rigid nasal endoscopy were then performed. Nasal symptom scores were assessed on a scale ranging from no symptoms to mild, moderate, and severe. Subsequently, the saccharin test was conducted to measure nasal mucociliary clearance time (MCT). Acoustic rhinometry was used to measure the nasal volume and MCA of both nasal cavities, before and after administration of 3% ephedrine nasal spray. Saccharin Test The subjects were asked to avoid sweet diet at least 2 h before the test and were then placed in upright position. The nasal speculum was applied into right nasal cavity. The saccharin was placed at 1 cm posterior to the head of right inferior turbinate with a standard measuring spoon. The subjects were asked not to sniff, sneeze, or flex his head. Time duration was recorded starting from saccharin placement to when they reported the sweet taste in their throat. If they did not report sweet taste until 30 min, the same amount of saccharin would be placed on their tongues. The result was recorded as “more than 30 min” if they tasted sweet taste. If they did not taste sweet taste, the result was recorded as “no taste was felt.” Acoustic Rhinometry Acoustic rhinometry (ECCOVISION NASAL Acoustic Rhinometer version 4.41; Sleep group solutions) was used to measure the nasal volume with the analysis segment of 0–6 cm and minimal cross‐sectional area (MCA). The subjects were placed in upright position. The appropriated size of nasal applicator was placed on left anterior nares. The machine produced sound into nasal cavity and detected the reflective acoustic signal. Then, the attached computer calculated the data into required nasal parameters. Subjects were asked to hold their breath while the test was being operated. The acoustic rhinometry was performed to both nasal cavities before and after 3% ephedrine administration. The average of nasal volume and MCA of both side were used for calculation. Contractility Index Contractility index represent the dynamic responsiveness of nasal mucosal. The contractility capacity was presented according to the change in parameter before and after decongestant administration. Contractility index for both MCA and nasal volume were calculated based on the following formula [19]: ContractilityIndex(%)=[(post−decongestantvalue/pre−decongestantvalue)×100]−100. Statistical Analysis Statistical analysis was performed using SPSS version 22.0 (SPSS Inc., Chicago, IL). Categorical data were presented as numbers and percentages. Continuous data were presented as means and standard deviations (SD). An independent‐samples t‐test was used to compare quantitative data with a normal distribution, while the Mann–Whitney U test was used for non‐normally distributed data. Correlations between continuous variables and nasal parameters were assessed using Pearson's correlation if both variables were normally distributed or if one variable was binary, and Spearman's correlation otherwise. Multiple linear regression analysis was used to assess associations between related variables and MCT, nasal volume, and MCA. A p‐value ≤ 0.05 was considered statistically significant. Results Demographics A total of 40 patients were recruited. Twenty were in TL group and 20 in control group. Baseline characteristics of both groups were shown in Table 1. The average age of TL group was (63.46 ± 1.94) years while the average age of control group was (49.37 ± 1.89) years. The significant differences in age between two groups were due to the limitation of subject's recruitment. Mean body mass index (BMI) of the control group was (26.2 ± 4.6) kg/m2, whereas that of TL group was (22.9 ± 3.3) kg/m2 (p = 0.01). The percentage of patients with hypertension was slightly higher in patients’ group (55%). There were no significant differences in smoking or alcohol drinking history between the two groups. However, the amount of smoking was higher in the TL group (20 pack‐year). There were no significant differences in other underlying diseases, sex, and other parameters between two groups. Table 1Baseline characteristics of patients who underwent total laryngectomy (TL) and controls.CharacteristicsControls (n = 20)TL (n = 20) p valueSex: male, no. (%)20 (100)20 (100)Age (years)49.37 ± 1.8963.46 ± 1.94< 0.01a, b Age range, no. (%)< 50 years11 (55)1 (5)50 to < 60 years8 (40)7 (35)60 to < 70 years0 (0)6 (30)≥ 70 years1 (5)6 (30)BMI (kg/m2)26.2 ± 4.622.9 ± 3.30.01a, c BMI range, no. (%)Underweight (below 18.5)1 (5)3 (15)Average (18.5–24.9)8 (40)13 (65)Overweight (25–29.9)5 (25)4 (20)Obese (30 or greater)6 (30)0 (0)Underlying disease, no. (%)HT4 (20.0)11 (55.0)0.02a, d Dyslipidemia2 (10.0)2 (10.0)1.00e DMT23 (15.0)3 (15.0)1.00e Old pulmonary TB0 (0.0)4 (20.0)0.11e Cardiac disease0 (0.0)3 (15.0)0.23e Others1 (5.0)5 (25.0)0.18e Smoking, no. (%)14 (70.0)18 (90.0)0.23e Amount of smoking (pack‐year)7.8 ± 1.921.0 ± 2.80.01a, b Alcohol drinking, no. (%)14 (70.0)16.0 (80.0)0.46d Duration of alcohol drinking11.8 ± 2.526.5 ± 2.70.21b Abbreviations: BMI, body mass index; HT, hypertension; DMT2, diabetes mellitus type 2; TB, tuberculosis. a Statistically significant. b Mann–Whitney U test. c Independent t‐test. d χ 2 test. e Fisher's exact test.John Wiley & Sons, Ltd. Baseline characteristics of patients who underwent total laryngectomy (TL) and controls. Abbreviations: BMI, body mass index; HT, hypertension; DMT2, diabetes mellitus type 2; TB, tuberculosis. Statistically significant. Mann–Whitney U test. Independent t‐test. χ 2 test. Fisher's exact test. Characteristics of TL Group In TL group, the characteristics of laryngeal cancer were shown in Table 2. Most of the laryngeal cancer was glottic cancer (70%). The cancer stage at the time of surgery was T4a (n = 13), followed by T3 (n = 5), T2 (n = 1), and T4b (n = 1). All patients had squamous cell carcinoma except for one patient who had adenosquamous carcinoma. All patients completed postoperative radiotherapy. The median time of postoperative duration was 16 months (IQR = 12.16 to 29.01 months), and its minimum and maximum value were 6.87 and 40.71 months, respectively. Majority of the patients in our study had a postoperative duration between 12 and 18 months. Table 2Characteristics of patients underwent total laryngectomy.ItemsNo. (%)StagingT21 (5)T35 (25)T4a13 (65)T4b1 (5)Type of cancerGottis14 (70)Supraglottis4 (20)Subglottis1 (5)Transglottis1 (5)PathologySquamous cell carcinoma19 (95)Adenosquamous carcinoma1 (5)Postoperative duration6–12 months4 (20)12–18 months6 (30)18–24 months4 (20)24–30 months2 (10)30–36 months2 (10)> 36 months2 (10)John Wiley & Sons, Ltd. Characteristics of patients underwent total laryngectomy. Objective Nasal Parameters Table 3 demonstrated the differences in MCT, nasal volume, MCA, and contractility index between the TL and the control group. The average mean of MCT was significantly longer in the TL group (10.99 ± 8.41 min) compared with that in control group (6.69 ± 3.72 min) (p = 0.05). The mean of nasal volume and MCA were not significantly different between TL and control group (p = 0.77 and 0.31, respectively). The mean nasal volume was (7.49 ± 2.08) cm3 in TL group and (7.68 ± 2.05) cm3 in control group, while the MCAs were (0.61 ± 0.14) cm2 in TL group and (0.57 ± 0.12) cm2 in control group. The change in nasal volume and MCA after administration of topical decongestant also demonstrated no difference between the two groups. The mean nasal volume change was (2.78 ± 1.77) cm3 in TL group and (2.28 ± 1.59) cm3 in control group (p = 0.35), while the change in MCAs was (0.09 ± 0.08) cm2 in TL group and (0.07 ± 0.09) cm2 in control group (p = 0.55). Additionally, the nasal contractility index for both nasal volume and MCA also showed no difference between both groups (p = 0.13 and 0.64, respectively). Table 3Data on mucociliary clearance time (MCT), nasal volume, minimal cross‐sectional area (MCA) and contractility index for nasal volume and MCA.ParametersControl (n = 20)TL (n = 20) p‐valueMCT (min)6.69 ± 3.7210.99 ± 8.410.05a, b Nasal volume (cm3)Volume7.68 ± 2.057.49 ± 2.080.77b Volume change2.28 ± 1.592.78 ± 1.770.35b Contractility index for nasal volume (%)33.71 ± 31.5942.32 ± 27.160.13c MCA (cm2)MCA0.57 ± 0.120.61 ± 0.140.31b MCA change0.07 ± 0.090.09 ± 0.080.55b Contractility index for MCA (%)14.96 ± 18.6217.06 ± 17.150.64c a Statistically significant. b Independent t‐test. c Mann–Whitney U test.John Wiley & Sons, Ltd. Data on mucociliary clearance time (MCT), nasal volume, minimal cross‐sectional area (MCA) and contractility index for nasal volume and MCA. Statistically significant. Independent t‐test. Mann–Whitney U test. Correlation Between Clinical Variables and Nasal Parameters Table 4 showed correlation analysis data between clinical variables and nasal parameters (MCT, nasal volume, and MCA). Nasal volume was significantly correlated with the postoperative duration (Spearman's rank correlation coefficient = 0.55; p = 0.01) as well as the MCA (Spearman's rank correlation coefficient = 0.64, p < 0.01), while the correlation between postoperative duration and MCT was weak (Spearman's rank correlation coefficient = 0.22, p = 0.35). On demographics, the history of alcohol drinking was negatively correlated with nasal volume (Pearson correlation coefficient = ‐0.51, p = 0.02). Age, BMI, underlying diseases and amount of smoking were not correlated with nasal outcomes. Table 4Correlation analysis data between clinical variables and nasal parameters.MCTNasal volumeMCAClinical parameters r p‐value r p‐value r p‐valueAgeb 0.360.120.200.400.02a 0.93BMIb −0.170.460.290.210.370.11Underlying diseasec HTc −0.200.390.030.900.020.92Dyslipidemiac −0.240.300.060.800.040.88DMT2c −0.180.440.150.520.040.86Amount of smoking (pack‐year)b −0.210.38−0.270.24−0.150.53Alcohol drinkingc −0.270.25−0.510.02a −0.360.12Postoperative durationb 0.220.350.550.01a 0.64 < 0.01a Note: r = correlation coefficient.Abbreviations: BMI, body mass index; DMT2, diabetes mellitus type 2; HT, hypertension; MCA, minimal cross‐sectional area; MCT, mucociliary clearance time. a Statistically significant. b Spearman correlation. c Pearson correlation.John Wiley & Sons, Ltd. Correlation analysis data between clinical variables and nasal parameters. Note: r = correlation coefficient. Abbreviations: BMI, body mass index; DMT2, diabetes mellitus type 2; HT, hypertension; MCA, minimal cross‐sectional area; MCT, mucociliary clearance time. Statistically significant. Spearman correlation. Pearson correlation. A multiple linear regression analysis was performed to evaluate the independent associations between nasal parameters and potential predictor variables, including postoperative duration, age, BMI, hypertension, amount of smoking, and alcohol intake. The model predicting MCA was statistically significant (R 2 = 0.66, p = 0.01), indicating that the included variables collectively explained 66% of the variance in MCA. In this model, postoperative duration (B = 0.10, p < 0.01) and smoking amount (B = 0.01, p = 0.04) were significantly associated with increased MCA. Other variables, including age, BMI, hypertension, and alcohol intake, were not statistically significant predictors (Table 5). In contrast, the models predicting MCT and nasal volume were not statistically significant (MCT: R 2 = 0.39, p = 0.28; nasal volume: R 2 = 0.54, p = 0.07). Table 5Multivariate analysis of predictors of average minimal cross‐sectional area in total laryngectomy group.Unstandardized coefficientsIndependent variablesBS.E.Standardized coefficient β 95% confidence interval p‐valueAge (years)−0.010.004−0.36−0.01 to 0.0020.14BMI (kg/m2)0.010.0080.35−0.002 to 0.0320.08Hypertension: no HT0.030.0560.12−0.087 to 0.1560.55Amount of smoking (pack‐year)0.010.0020.470.000 to 0.0100.04a Alcohol drinking: no drinking−0.140.083−0.41−0.318 to 0.0390.11Postoperative duration (months)0.010.0030.770.005 to 0.017< 0.01a a Statistically significantJohn Wiley & Sons, Ltd. Multivariate analysis of predictors of average minimal cross‐sectional area in total laryngectomy group. Statistically significant Nasal Symptoms in Total Laryngectomy Group Nasal symptoms following TL were reported by 14 patients (70%) in the TL group. The most commonly reported symptom was nasal discharge or postnasal drip (n = 11, 55%). Other symptoms included abnormal sense of smell (n = 8), sneezing (n = 7), nasal itching (n = 4), and dry nose (n = 4). Table 6 summarizes the severity of each nasal symptom. Table 6Nasal symptoms in total laryngectomy group.Nasal symptomsPost‐total laryngectomy (n = 20)%Severity, no. (%)MildModerateSevereNo symptom630———Congestion3153 (100)——Nasal itching4204 (100)——Nasal discharge, postnasal drip11554 (36.36)6 (54.54)1 (9.09)Sneezing7354 (57.14)3 (42.86)—Dry nose4202 (50)1 (25)1 (25)Nasal pain151 (100)——Epistaxis151 (100)——Abnormal sense of smell8402 (25)1 (12.5)5 (62.5)John Wiley & Sons, Ltd. Nasal symptoms in total laryngectomy group. Pearson correlation analysis was performed to assess the relationship between reported nasal symptoms and objective nasal parameters. Dry nose was found to be negatively correlated with the change in nasal volume after decongestant administration (r = –0.44, p = 0.05) and with the contractility index of nasal volume (r = –0.46, p = 0.04). No significant correlations were observed between the other nasal symptoms and nasal parameters. Discussion TL leads to changes in the nasal cavity due to the separation of the upper and lower airways. These changes have been well documented across various aspects, including nasal function, defense mechanisms, olfactory function, nasal structure (both macroscopic and microscopic), and bacterial colonization [8, 19, 20, 21, 22, 23, 24]. However, the correlation between these structural and functional changes and clinical symptoms remains underreported. Thus, this study compared nasal structure and function between patients who underwent TL and healthy controls, focusing on clinically relevant changes. MCT was significantly longer in the TL group compared to the control group, within a postoperative duration ranging from 6.87 to 40.71 months. This finding is consistent with previous studies conducted within similar postoperative periods, which also reported prolonged MCT in the TL group [6, 25, 26]. The dynamic changes in MCT appear to be influenced by the time elapsed after surgery. In the early postoperative stage, MCT tends to remain unchanged or may even be shorter [19, 21, 27, 28], which may explain the reduced frequency of inflammatory changes observed following TL during this period [7, 8]. Reduced MCT is due to the loss of nasal air conditioning, and reduced evaporation with retention of the watery component of mucus has been proposed as the mechanism [25]. Additionally, in some patients, the removal of harmful cigarette smoke exposure, common among heavy‐smoking laryngectomees, might contribute to improved nasal epithelial function. In contrast, over the long term, MCT tends to become prolonged as time progresses [6, 25, 26]. This prolongation may be attributed to atrophic changes and stromal fibrosis resulting from the destruction of goblet cells, cilia, and submucosal glands. These alterations are likely secondary to the cessation of nasal airflow and chronic bacterial colonization [7, 8, 10, 29]. No statistically significant differences were found between the TL and control groups in terms of mean nasal volume, MCA, and nasal contractility. Nonetheless, there was a positive correlation between postoperative duration and nasal dimensions in the TL group, suggesting reduced turbinate size and thus increased nasal volume and MCA over time. This may reflect atrophic changes in the turbinate as well as declining nasal function after cessation of airflow [13, 19]. Consistent with univariate analysis, multiple linear regression showed that clinical variables were significantly associated with objective nasal parameters. Specifically, the model predicting MCA was statistically significant, with postoperative duration and smoking amount being key predictors of increased MCA. Correlation analysis included potential confounding factors that differed at baseline between the two groups, namely age, BMI, comorbid hypertension, and smoking amount. Compared to the control group, patients in the TL group were older, had lower BMI, a higher prevalence of hypertension, and greater smoking exposure. These differences are consistent with the typical clinical profile of patients with laryngeal cancer. Despite these baseline differences, no significant associations were found between most of these variables and objective nasal outcomes, with the exception of smoking amount in the multivariate model. Therefore, smoking amount may act as a confounding factor in the TL group, as it contributes to increased MCA alongside postoperative duration. Previous data on objective nasal parameters after TL are limited and inconsistent. Ozgursoy et al. [22] reported decreased nasal cavity volume and MCA values 2 years post‐TL, along with symptomatic nasal obstruction. In contrast, Wei et al. [13] found that MCA and nasal volume were increased 1 year post‐TL compared to healthy controls. A more recent study by Kocak et al. [19] found no significant change in MCA values after TL; however, they observed a reduction in the contractile capacity of the inferior turbinate over time (6–12 months postoperatively). Nasal symptoms were reported despite the absence of nasal airflow after TL. In this study, 70% of patients reported nasal symptoms following TL, consistent with previous findings. The rhinologic domain of the Sinonasal Outcome Test (SNOT‐22) was significantly higher in the TL group compared to the non‐laryngectomy group. A more detailed assessment of nasal symptoms using a visual analog scale revealed worse scores for nasal congestion, rhinorrhea, postnasal drip, and olfactory function [11]. Of note, elevated SNOT‐22 scores did not consistently correspond with radiographic abnormalities [29]. While nasal congestion and other symptoms often reflect underlying anatomical changes on imaging, olfactory dysfunction is frequently reported even when imaging findings are normal. This suggests that olfactory loss rather than structural nasal disease may be a key driver of patient complaints in this group [30, 31, 32]. The relationship between nasal symptoms and objective nasal assessments was also examined. Among the presence of nasal symptoms after TL, dry nose showed a negative correlation with the nasal volume contractility index, whereas no significant correlations were found between other symptoms and objective measurements. These findings support the hypothesis that reduced contractility over time may result from turbinate atrophy and diminished vascular activity following TL [19]. The findings of this study reinforce existing evidence, contributing to a better understanding of the effects of TL on nasal function, both subjectively and objectively, in a different geographic context. Furthermore, the exploration of associations between clinical factors and nasal parameters may enhance our understanding and help predict post‐surgical outcomes. This could inform the planning of therapeutic strategies, such as local nasal care or intranasal medications. However, this study has several limitations. First, there are limitations related to the study design. The cross‐sectional nature of the data, collected at a single time point, restricts the ability to assess dynamic changes in the nasal cavity over time. Future longitudinal studies with larger sample sizes would be valuable for a more comprehensive evaluation of these temporal changes. Second, baseline differences in age, BMI, and comorbid HT were observed between the two groups. However, correlation analysis did not demonstrate any significant association between these variables and nasal patency, suggesting that they have a limited impact on the study outcomes. Third, potential confounding effects of radiation therapy and smoking should be considered. All patients in the TL group had received radiation therapy, which may have influenced nasal dimensional outcomes. Despite this, a significant correlation between nasal parameters and postoperative duration was observed. This likely reflects the long‐term effects of TL, indicating that nasal changes become more pronounced over time, while the impact of radiation may diminish. In addition, smoking amount may act as a confounding factor in long‐term changes in nasal patency, particularly in relation to increased MCA after TL within the multivariate model, alongside postoperative duration, as mentioned earlier. Therefore, future studies with better‐controlled baseline characteristics are warranted to minimize these confounding effects and to further clarify the independent contributions of these variables. Conclusion In this study, nasal MCT was significantly prolonged in the TL group compared to controls, despite no significant differences in nasal volume, MCA, or nasal contractility. Nasal symptoms were prevalent postoperatively, and both postoperative duration and cumulative smoking exposure were associated with increased MCA, suggesting that smoking may act as a potential confounding factor in nasal dimensional outcomes. In addition, reduced nasal volume and contractility were associated with the presence of dry nose symptoms. Overall, these findings suggest an effect of nasal airflow deprivation on nasal physiology, while highlighting the potential influence of confounding factors such as smoking, and may inform the development of targeted interventions to address nasal dryness. Author Contributions All authors contributed substantially to this work. Kajornpan Sermwittayawong designed the study, performed data collection, and drafted manuscript. Paraya Assanasen was responsible for patient recruitment and data collection. Phawin Keskool supervised the project and provided critical oversight. Dichapong Kanjanawasee performed the statistical analysis, interpreted the data, and drafted the manuscript. Ethics Statement The study was approved by the Siriraj Institutional Review board (SIRB), Faculty of Medicine Siriraj Hospital, Mahidol University (SIRB Protocol No. 383/2562). Conflicts of Interest The authors declare no conflicts of interest.